Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Hovione and Merrion Pharmaceuticals [ESM; MERR] announced today that they have concluded a strategic partnership directed to the use of Merrion’s patented GIPET absorption enhancing technology by Hovione clients. Hovione, an international contract ...
read more
Tuesday, February 22, 2022
Hovione a provider of spray drying and particle engineering, announced a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
read more
Hovione announced a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities.
read more
Thursday, September 08, 2022
Hovione has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal.
read more
Tuesday, November 23, 2021
Hovione, a global provider of spray drying and particle engineering services announced that it is expanding its New Jersey site in East Windsor, laying the foundations for a state-of-the-art Hovione Campus.
read more
Wednesday, March 07, 2018
Hovione has concluded the sale of all of the share capital of iMAX Diagnostic Imaging.
read more
Friday, December 29, 2017
HTG Molecular Diagnostics announced a new Master Collaboration Agreement for translational programs with Merck KGaA, Darmstadt, Germany.
read more
Thursday, August 20, 2020
Humanetics and Pii will work together to support a clinical trial of BIO 300 in COVID-19 patients.
read more
Wednesday, February 09, 2022
Humanigen, Inc. and Cenexi, a French CDMO, announced a collaboration aimed at making Cenexi a preferred supplier of lenzilumab in France and the European Union. The initial step of the collaboration includes the execution of a Master Supply Agreement...
read more
Humanigen, Inc. announced it entered into an agreement with PCI Pharma Services (PCI), a integrated global contract development manufacturing organization (CDMO), to provide importation, release and commercialization services in the United Kingdom (...
read more
Catalent will provide development, manufacturing and commercialization services for lenzilumab, Humanigen’s anti-human GM-CSF monoclonal antibody.
read more
Tuesday, October 12, 2021
Humanigen announced it has entered into an arrangement with Clinigen to implement a Managed Access Program for lenzilumab (“LenzMAP™”).
read more
Monday, February 08, 2021
Avid Bioservices and Humanigen have entered into a manufacturing services agreement to expand production capacity for lenzilumab, Humanigen’s therapeutic candidate in development for COVID-19.
read more
Monday, September 28, 2020
Humanigen announced a strategic collaboration with Thermo Fisher Scientific to expand the manufacturing capacity for lenzilumab, currently in a Phase 3 registration study in patients with COVID-19.
read more
Monday, September 18, 2017
PuraCap announced the FDA has completed a successful general inspection of its affiliated soft gelatin capsule manufacturing facility located in Wuhan, Hubei Province China.
read more